Insiders who reported open-market trades in the last 12 months at the companies Robert M. Plenge files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
George Eric Davis - $2.76M in BMRN purchases and sales in the last 12 months
Charles Greg Guyer - $997K in BMRN purchases and sales in the last 12 months
Gregory R. Friberg - $559K in BMRN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Robert M. Plenge is a corporate insider, tracked as Director of BIOMARIN PHARMACEUTICAL INC (BMRN). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Robert M. Plenge submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
InsiderAlpha's records for Robert M. Plenge go back to 2026: 2 primary Form 4 filings, an average of 2.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.